These findings deepen our understanding of the pathogenesis of DVT and provide novel therapeutic targets (CBT15_circR_28491-miR-139-3p-Kif18a/Cdca8/Nek2) for DVT management. The gene discussed is NEK2; the disease is deep vein thrombosis.